---
schema_version: "secwatch.filing_event.v1"
accession: "0000899923-26-000062"
form_type: "8-K"
ticker: "MYGN"
cik: "0000899923"
company_name: "MYRIAD GENETICS INC"
filed_at: "2026-06-23T12:32:15+00:00"
generated_at: "2026-06-23T12:35:18.769689+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Myriad Genetics director Daniel M. Skovronsky resigns effective June 17, 2026

## Summary
- Daniel M. Skovronsky resigned from Myriad Genetics board effective June 17, 2026.
- Resignation was not due to any disagreement with the company or its operations.
- Myriad Genetics (MYGN) filed Form 8-K on June 23, 2026 to report the departure.
- Skovronsky served as a director prior to resignation.

## SEC filing metadata
- accession: 0000899923-26-000062
- form_type: 8-K
- ticker: MYGN
- cik: 0000899923
- company_name: MYRIAD GENETICS INC
- filed_at: 2026-06-23T12:32:15+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899923/000089992326000062/0000899923-26-000062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899923/000089992326000062/mygn-20260617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000899923-26-000062
- JSON: https://secwatch.observer/filing/0000899923-26-000062.json
- Plain text: https://secwatch.observer/filing/0000899923-26-000062.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.